TyRx Launches AIGISRX(TM) ICD To Reduce Surgical Site Infections Associated With Implantable Cardioverter Defibrillators
admin TyRx, Inc., a cheater in the utilization and development of focused drug-device scrutiny products, declared today the start of AIGISRX(TM) ICD, an anti-bacterial bag matured to support alter the established figure and which also contains anti-microbial agents that support wage endorsement against preoperative place infections (SSI) related with implantable cardioverter defibrillators (ICDs).
Tags: Launch
Posted in Cardiology |